FDA Import Refusal 799-2585627-7/11/1 — DOUGLAS PHARMACEUTICALS
The FDA refused shipment 799-2585627-7/11/1 from DOUGLAS PHARMACEUTICALS (New Zealand) on Sep 18, 2017. The refused product falls under Drugs and Biologics — DILTIAZEM HYDROCHLORIDE (ANTI-HYPERTENSIVE - PART II). Cited charge: 75 This firm has 1 other import refusal on record.
Refusal details
- Date
- Sep 18, 2017
- Country
- New Zealand
- Product Category
- Drugs and Biologics
- Product Code
- 62OCY24 DILTIAZEM HYDROCHLORIDE (ANTI-HYPERTENSIVE - PART II)
- Charges
- 75